World Courier, a global specialty logistics provider and a part of Cencora, announced the appointment of Laurent Bendavid as the new president and senior vice president of World Courier.
Neuraxpharm reaches 98% of the European CNS market through its presence in more than 20 countries and, with a direct presence in Latin America and the Middle East.
Infinitopes’ lead vaccine candidate ITOP1 is a novel, precision targeted “off-the-shelf” cancer vaccine, designed to save lives by preventing disease recurrence in first-line patients with surgically resectable cancers.
Adragos Pharma has significantly enhanced its production capabilities with the completion of a new ampoule filling line at its Livron-sur-Drôme site in France.
Gifthealth will serve as the exclusive platform for patient education and medication adherence for United Digestive, thanks to a newly announced strategic partnership.
Pheast Therapeutics announced the presentation of new preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage "don't eat me" signal on cancer cells.
Cencora bolstered the support it can offer to pharmaceutical companies through the addition of Public Health Expertise (PHE), a France-based life sciences consulting firm that specialises in market access, health economics and outcomes research.
